PYC Therapeutics Limited (AU:PYC) has released an update.
PYC Therapeutics Limited has reported a significant rise in income by 43.7% year-over-year to $22,855,290, yet also a substantial increase in net loss of 65.5% to $(37,725,411) for the fiscal year ending June 30, 2024. The company has not declared any dividends during this period and has bolstered its stake in Vision Pharma Limited to 96.2%. Furthermore, the net tangible assets per share have more than doubled from 0.71 cents to 1.67 cents.
For further insights into AU:PYC stock, check out TipRanks’ Stock Analysis page.
